ArticleJournal of hepatocellular carcinoma2022

Efficacy and Safety of TKI Plus PD-1 Inhibitors in Elderly uHCC Patients: A Retrospective Study.

Bowen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.